Publication:
Malaria in pregnancy in the Asia-Pacific region

dc.contributor.authorMarcus J. Rijkenen_US
dc.contributor.authorRose McGreadyen_US
dc.contributor.authorMachteld E. Boelen_US
dc.contributor.authorRini Poespoprodjoen_US
dc.contributor.authorNeeru Singhen_US
dc.contributor.authorDin Syafruddinen_US
dc.contributor.authorStephen Rogersonen_US
dc.contributor.authorFrançois Nostenen_US
dc.contributor.otherShoklo Malaria Research Uniten_US
dc.contributor.otherUniversity of Oxforden_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherMenzies School of Health Researchen_US
dc.contributor.otherMimika District Health Authorityen_US
dc.contributor.otherIndian Council of Medical Researchen_US
dc.contributor.otherNational Institute of Malaria Research Indiaen_US
dc.contributor.otherEijkman Institute for Molecular Biologyen_US
dc.contributor.otherUniversity of Melbourneen_US
dc.date.accessioned2018-06-11T05:20:37Z
dc.date.available2018-06-11T05:20:37Z
dc.date.issued2012-01-01en_US
dc.description.abstractMost pregnant women at risk of for infection with Plasmodium vivax live in the Asia-Pacific region. However, malaria in pregnancy is not recognised as a priority by many governments, policy makers, and donors in this region. Robust data for the true burden of malaria throughout pregnancy are scarce. Nevertheless, when women have little immunity, each infection is potentially fatal to the mother, fetus, or both. WHO recommendations for the control of malaria in pregnancy are largely based on the situation in Africa, but strategies in the Asia-Pacific region are complicated by heterogeneous transmission settings, coexistence of multidrug-resistant Plasmodium falciparum and Plasmodium vivax parasites, and different vectors. Most knowledge of the epidemiology, effect, treatment, and prevention of malaria in pregnancy in the Asia-Pacific region comes from India, Papua New Guinea, and Thailand. Improved estimates of the morbidity and mortality of malaria in pregnancy are urgently needed. When malaria in pregnancy cannot be prevented, accurate diagnosis and prompt treatment are needed to avert dangerous symptomatic disease and to reduce effects on fetuses. © 2012 Elsevier Ltd.en_US
dc.identifier.citationThe Lancet Infectious Diseases. Vol.12, No.1 (2012), 75-88en_US
dc.identifier.doi10.1016/S1473-3099(11)70315-2en_US
dc.identifier.issn14744457en_US
dc.identifier.issn14733099en_US
dc.identifier.other2-s2.0-84055192692en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/15117
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84055192692&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleMalaria in pregnancy in the Asia-Pacific regionen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84055192692&origin=inwarden_US

Files

Collections